NAEF; Reto

Patent Applications and Registrations

Patent applications and USPTO patent grants for NAEF; Reto.The latest application filed is for "2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof".

Company Profile

3.9.14

NAEF; Reto - Schlieren CH
NAEF; Reto - Rheinfelden CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone Derivatives As Phosphodiesterase Inhibitors And Uses Thereof App 20220169655 - NAEF; Reto ; et al.	2022-06-02
Dual Mode Of Action Soluble Guanylate Cyclase Activators And Phosphodiesterase Inhibitors And Uses Thereof App 20220073529 - NAEF; Reto ; et al.	2022-03-10
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof Grant 11,242,347 - Naef , et al. February 8, 2	2022-02-08
Novel Dual Mode Of Action Soluble Guanylate Cyclase Activators And Phosphodiesterase Inhibitors And Uses Thereof App 20220031704 - KOCH; Guido ; et al.	2022-02-03
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof Grant 11,155,558 - Naef , et al. October 26, 2	2021-10-26
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone Derivatives As Phosphodiesterase Inhibitors And Uses Thereof App 20200239478 - NAEF; Reto ; et al.	2020-07-30
Novel Dual Mode Of Action Soluble Guanylate Cyclase Activators And Phosphodiesterase Inhibitors And Uses Thereof App 20200181149 - NAEF; Reto ; et al.	2020-06-11
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof Grant 10,570,137 - Naef , et al. Feb	2020-02-25
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone Derivatives As Phosphodiesterase Inhibitors And Uses Thereof App 20180312513 - NAEF; Reto ; et al.	2018-11-01
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors Grant 7,361,661 - Bhalay , et al. April 22, 2	2008-04-22
cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction App 20070197560 - Naef; Reto	2007-08-23
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors App 20060173181 - Bhalay; Gurdip ; et al.	2006-08-03
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors App 20060106214 - Bhalay; Gurdip ; et al.	2006-05-18
8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors Grant 7,019,136 - Bhalay , et al. March 28, 2	2006-03-28
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors App 20050054660 - Bhalay, Gurdip ; et al.	2005-03-10
cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction App 20040214831 - Naef, Reto	2004-10-28
8-Quinolinxanthine and 8-isoquinolinxant hine derivatives as PDE 5 inhibitors App 20040038996 - Bhalay, Gurdip ; et al.	2004-02-26
8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors App 20030171384 - Bhalay, Gurdip ; et al.	2003-09-11
cGMP PDE 5 Inhibitors for inhalation in the treatment of sexual dysfunction App 20010055570 - Naef, Reto	2001-12-27
Tetracyclic triterpenes Grant 5,852,005 - Hiestand , et al. December 22, 1	1998-12-22
O-acylated cyclosporins Grant 5,643,870 - Boelsterli , et al. July 1, 1	1997-07-01
Dihydro-isoquinoline derivatives, processes for their production, pharmaceutical compositions containing them, and their use in treating asthma Grant 5,177,085 - Naef January 5, 1	1993-01-05
Isoquinoline derivatives and their use Grant 4,980,359 - Hasspacher , et al. December 25, 1	1990-12-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.